Retrouvez l'article sur le site de l'Inserm
Source : Mittelheisser, V., Gensbittel, V., Bonati, L. et al. Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases. Nat. Nanotechnol. (2024). doi-org.proxy.insermbiblio.inist.fr/10.1038/s41565-023–01535‑8
Source : Mittelheisser, V., Gensbittel, V., Bonati, L. et al. Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases. Nat. Nanotechnol. (2024). doi-org.proxy.insermbiblio.inist.fr/10.1038/s41565-023–01535‑8
Source : Mittelheisser, V., Gensbittel, V., Bonati, L. et al. Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases. Nat. Nanotechnol. (2024). doi-org.proxy.insermbiblio.inist.fr/10.1038/s41565-023–01535‑8
Source : Mittelheisser, V., Gensbittel, V., Bonati, L. et al. Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases. Nat. Nanotechnol. (2024). doi-org.proxy.insermbiblio.inist.fr/10.1038/s41565-023–01535‑8
Source : Mittelheisser, V., Gensbittel, V., Bonati, L. et al. Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases. Nat. Nanotechnol. (2024). doi-org.proxy.insermbiblio.inist.fr/10.1038/s41565-023–01535‑8
Source : Mittelheisser, V., Gensbittel, V., Bonati, L. et al. Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases. Nat. Nanotechnol. (2024). doi-org.proxy.insermbiblio.inist.fr/10.1038/s41565-023–01535‑8